These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8788915)

  • 21. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine.
    Bardgett ME; Salaris SL; Jackson JL; Harding J; Csernansky JG
    Psychopharmacology (Berl); 1997 Sep; 133(2):142-51. PubMed ID: 9342780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization and enhancement of neurotensin/neuromedin N mRNA responses in subsets of rat caudate-putamen neurons following multiple administrations of haloperidol.
    Zahm DS; Williams ES; Krause JE
    Brain Res Mol Brain Res; 1998 Aug; 59(2):196-204. PubMed ID: 9729381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.
    Huang W; Hanson GR
    Eur J Pharmacol; 1997 Jul; 332(1):15-21. PubMed ID: 9298921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone does not elevate neurotensin mRNA in rat nucleus accumbens and caudate-putamen.
    Mijnster MJ; Docter GJ; Voorn P
    Neuroreport; 1995 Nov; 6(16):2209-12. PubMed ID: 8595204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala.
    Essig EC; Kilpatrick IC
    Psychopharmacology (Berl); 1991; 104(2):194-200. PubMed ID: 1876664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of short- and long-term haloperidol administration and withdrawal on regional brain cholecystokinin and neurotensin concentrations in the rat.
    Radke JM; MacLennan AJ; Beinfeld MC; Bissette G; Nemeroff CB; Vincent SR; Fibiger HC
    Brain Res; 1989 Feb; 480(1-2):178-83. PubMed ID: 2713650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.
    Youngren KD; Inglis FM; Pivirotto PJ; Jedema HP; Bradberry CW; Goldman-Rakic PS; Roth RH; Moghaddam B
    Neuropsychopharmacology; 1999 May; 20(5):403-12. PubMed ID: 10192821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subsets of neurotensin-immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum.
    Zahm DS
    Neuroscience; 1992; 46(2):335-50. PubMed ID: 1542410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
    Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of haloperidol, quinelorane, and lithium on regional neurotensin/neuromedin N concentrations: further evidence for neurotensin/neuromedin N-dopamine interactions.
    Clement R; Griff D; Banks B; Nemeroff C; Kitabgi P; Bissette G
    Synapse; 1994 Aug; 17(4):241-6. PubMed ID: 7992199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic haloperidol does not alter G protein alpha-subunit levels in rats.
    See RE; Striplin C; Kalivas PW
    Brain Res Mol Brain Res; 1993 Aug; 19(3):219-21. PubMed ID: 8412564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
    Liégeois JF; Ichikawa J; Meltzer HY
    Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats.
    Grimm JW; See RE
    Neuroscience; 2000; 100(3):507-14. PubMed ID: 11098113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
    Kilpatrick IC; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.
    Zhang Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 2003 Dec; 50(3):191-9. PubMed ID: 14515336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of the releasable pool of CCK in the rat nucleus accumbens and caudate-putamen following lesions of the midbrain.
    Maidment NT; Villafranca NP
    Brain Res; 1997 Feb; 747(2):290-6. PubMed ID: 9046004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.